Enrolling by Invitation
Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial
NCT06646978
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
- Locations
-
- CHU de Poitiers Poitiers, France